Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study (Q43205173)
Jump to navigation
Jump to search
scientific article published on 30 December 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study |
scientific article published on 30 December 2009 |
Statements
1 reference
Sorafenib plus octreotide is an effective and safe treatment in advanced hepatocellular carcinoma: multicenter phase II So.LAR. study (English)
1 reference
1 reference
1 reference
Salvatore Del Prete
1 reference
Liliana Montella
1 reference
Luigi Maiorino
1 reference
Gregorio Cennamo
1 reference
Vincenzo Montesarchio
1 reference
Guido Piai
1 reference
Antonio Febbraro
1 reference
Luciano Tarantino
1 reference
Elena Capasso
1 reference
Giovannella Palmieri
1 reference
Rosario Guarrasi
1 reference
Maddalena Bianco
1 reference
Rosanna Mamone
1 reference
Clementina Savastano
1 reference
Agata Pisano
1 reference
Antonietta Sabia
1 reference
Alberto D'Agostino
1 reference
Vincenzo Faiola
1 reference
Raffaele Addeo
1 reference
30 December 2009
1 reference
1 reference
66
1 reference
5
1 reference
837-844
1 reference
Identifiers
1 reference
1 reference